|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Afferent Pharmaceuticals, Inc.
| | | Phone: | (650) 286-1276 | Fax: | (650) 286-1833 | Year Established: | 2009 | Ticker: | MRK | Exchange: | NYSE | Main Contact: | Kathleen Sereda Glaub, CEO | | Other Contacts: | Michelle Carpenter, JD, RAC, VP, Regulatory Affairs & Project Management Prabha Ibrahim, Ph.D., CTO Peter G. Butera, VP, Clinical Operations Michael Kitt, MD, CMO Anthony P. Ford, Ph.D., CSO
| | Company Description | Afferent Pharmaceuticals, a Merck subsidiary, is a clinical-stage biotechnology company and leader in the development of novel drugs for the treatment of a range of debilitating neurogenic disorders. | |
|
|
|
|
|